
A retrospective cohort study assessed the risks of post-colonoscopy thromboembolic (TE) events and their association with the interruption of antithrombotic agents. Among 6,220 patients, 28.2% were on antithrombotics, with 0.32% experiencing TE events. Patients on dual-antiplatelet therapy and clopidogrel had the highest TE rates. Temporary interruption of antithrombotic agents, especially stopping 2 or more agents, clopidogrel, warfarin, or direct-acting oral anticoagulants, increased the risk of postcolonoscopy TE events, particularly in high-risk patients with underlying high TE risk.
Like
Save
Share